Skip to main content

Radiohalogenated L-α-Methyltyrosines as Potential Pancreas Imaging Agents for PECT and SPECT

  • Chapter
Progress in Radiopharmacology 3

Part of the book series: Developments in Nuclear Medicine ((DNUM,volume 2))

Abstract

The diagnosis of pancreatic carcinoma is still a problem in nuclar medicine (1), and an improved pancreas imaging agent is urgently needed. Currently, L-I75Se)-seleno-methionine (SM) is used as an agent for the detection of pancreatic carcinoma (2), with 99mTc sulfur colloid often injected in addition in order to permit the substraction of the interfering liver back-ground from SM (3). This imaging procedure results in rather large radiation doses to the patient, especially since the biological half-time of SM (70 days) is comparable with the physical half-life (120 days) of 75Se (4). Additionally, significant numbers of false-positives and false-negatives make routine diagnosis difficult (5).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. McAfee JG. In: Radiopharmaceuticals. The Society of Nuclear Medicine, Subramanian G, Rhodes BA, Cooper JF et al. (eds), New York, 3:14, 1975.

    Google Scholar 

  2. Blau M, Manske RF, J. nucl. Med. 2: 102, 1961.

    Google Scholar 

  3. Zurowski S, Graban WT, Jabukowski W, Eur. J. nucl. Med. 2: 273, 1977.

    Article  PubMed  CAS  Google Scholar 

  4. Lathrop KA, Johnston RE, Blau M, Rothschild EO, J. Nucl. Med. 13, suppl. 6: 7, 1972.

    Google Scholar 

  5. Quinn JL, III. In: Nuclear Medicine, Wagner HN, Jr, (ed), HP Publising Comp. New York, 153–160, 1975.

    Google Scholar 

  6. Hoyte RM, Lin SS, Christman DR, Atkins HL, Hauser W, Wolf AP, J. nucl. Med. 12: 280, 1971.

    PubMed  CAS  Google Scholar 

  7. Atkins HL, Christman DR, Fowler JS, Hauser W, Hoyte RM, Klopper JF, Lin SS, Wolf AP, J. nucl. Med. 13: 713, 1972.

    PubMed  CAS  Google Scholar 

  8. Lambrecht RM, Atkins H, Elias H, Fowler JS, Lin SS, Wolf AP, J. nucl. Med. 15: 863, 1974.

    PubMed  CAS  Google Scholar 

  9. Vaalburg W, Beerling-van der Molen HD, Woldring MG, Nucl. Med. 14: 60, 1975.

    CAS  Google Scholar 

  10. Washburn LC, Wieland BW, Sun TT, Hayes RL, Butler TA, J. nucl. Med. 19: 77, 1978.

    PubMed  CAS  Google Scholar 

  11. Kung HF, Gilani S, Blau M, J. nucl. Med. 19: 393, 1978.

    PubMed  CAS  Google Scholar 

  12. Washburn LC, Sun TT, Byrd BL, Hayes RL, Butler TA, J. nucl. Med. 20: 857, 1979.

    PubMed  CAS  Google Scholar 

  13. Comar D, Cartron JC, Mazière M, et al. Eur. J. nucl. Med. 1: 11, 1976.

    Article  PubMed  CAS  Google Scholar 

  14. Syrota A, Comar D, Cerf M, Plummer D, Mazière M, Kellershohn C, J. nucl. Med. 20: 778, 1979.

    PubMed  CAS  Google Scholar 

  15. Buonocore E, Hübner KF, Radiology 133: 195, 1979.

    PubMed  CAS  Google Scholar 

  16. Hübner KF, Andrews GA, Buonocore E, Hayes RL, Washburn LC, Collmann IR, Gibbs WD, J. nucl. Med. 20: 507, 1979.

    PubMed  Google Scholar 

  17. Duhm B, Maul W, Medenwald H, Patzschke K, Wegner LA, Z. Naturforschg. 20b: 434, 1965.

    CAS  Google Scholar 

  18. Duhm B, Maul W, Medenwald H, Patzschke K, Wegner LA, Schlossmann K, Z. Naturforschg, 22b: 70, 1967.

    CAS  Google Scholar 

  19. Tisljar U, Kloster G, Ritzl F, Stöcklin G, J. nucl. Med, 20: 973, 1979.

    PubMed  CAS  Google Scholar 

  20. Ritzl F, Kloster G, Coenen HH, Tisljar U, Stöcklin G, J. nucl. Med. 22: 87, 1981, (abstract).

    Google Scholar 

  21. Kloss G, Becker H, Niemann E, Leven M, Patent 21, 45, 282 (Fed. Rep. Germany) 1975.

    Google Scholar 

  22. Kloss G, Leven M, Eur. J. nucl. Med. 4: 179, 1979.

    Article  PubMed  CAS  Google Scholar 

  23. Petzold G, Coenen HH, J. Lab. comp. Radiopharm. 18:1319, 1981.

    Article  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1982 Martinus Nijhoff Publishers, The Hague

About this chapter

Cite this chapter

Kloster, G., Coenen, H.H., Szabo, Z., Ritzl, F., Stöcklin, G. (1982). Radiohalogenated L-α-Methyltyrosines as Potential Pancreas Imaging Agents for PECT and SPECT. In: Cox, P.H. (eds) Progress in Radiopharmacology 3. Developments in Nuclear Medicine, vol 2. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-7669-6_12

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-7669-6_12

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-009-7671-9

  • Online ISBN: 978-94-009-7669-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics